A detailed history of Strategic Financial Services, Inc, transactions in Abbott Laboratories stock. As of the latest transaction made, Strategic Financial Services, Inc, holds 3,413 shares of ABT stock, worth $349,252. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,413
Previous 3,468 1.59%
Holding current value
$349,252
Previous $381,000 1.57%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$109.52 - $120.96 $6,023 - $6,652
-55 Reduced 1.59%
3,413 $387,000
Q3 2023

Nov 06, 2023

SELL
$95.53 - $114.62 $66,871 - $80,234
-700 Reduced 16.79%
3,468 $335,000
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $24,187 - $26,949
240 Added 6.11%
4,168 $454,000
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $7,748 - $9,120
80 Added 2.08%
3,928 $397,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $3,802 - $4,460
40 Added 1.05%
3,848 $422,000
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $63,385 - $76,612
621 Added 19.49%
3,808 $414,000
Q4 2021

Feb 15, 2022

SELL
$115.53 - $141.46 $8,433 - $10,326
-73 Reduced 2.24%
3,187 $449,000
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $2,099 - $2,323
-18 Reduced 0.55%
3,260 $385,000
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $1,904 - $2,241
18 Added 0.55%
3,278 $380,000
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $16,905 - $18,421
-161 Reduced 4.71%
3,260 $357,000
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $70,654 - $85,804
-771 Reduced 18.39%
3,421 $372,000
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $64,299 - $71,580
-819 Reduced 16.34%
4,192 $364,000
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $96,128 - $112,115
1,319 Added 35.73%
5,011 $421,000
Q4 2018

Feb 11, 2019

BUY
$65.56 - $74.27 $242,047 - $274,204
3,692 New
3,692 $267,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Strategic Financial Services, Inc, Portfolio

Follow Strategic Financial Services, Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Financial Services, Inc,, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Financial Services, Inc, with notifications on news.